Novaliq

eyes
Biotech

Bausch-Novaliq's eye drop beats placebo again in phase 3 trial

Patients with dry eye disease taking Bausch + Lomb's eye drop reported an improvement in the severity of eye dryness during a phase 3 clinical trial.
Kyle LaHucik Sep 30, 2021 11:00am
Ladders

Chutes & Ladders—Allergan vet to replace Kaye as Sarepta’s CEO

Jun 30, 2017 7:33am
A close image of a blue eye

Ophthalmic CRO Ora kept in ocular clinical trial pact with Axim

Mar 29, 2017 2:19pm